Impact Factor
3.05
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.13
383 total citations
h5-index
18
h5 depth signal
Cited share
65.6%
122 of 186
Total citations
383
Citation footprint
Metric signal
2.02
External metric anchor
Self-citation
2.6%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
872
China
107
Canada
95
Italy
42
Pakistan
40
Citing Fields of Research
Oncology
501
Breast Cancer
166
Liver & Colon Cancer
144
Lung Cancer
136
Digestive Disorders
135
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
6,042
Articles tracked across the journal lifetime
Indexed publication set
186
122 cited publications
Last 12 months
125
10.4 publications/month
Open access share
8.8%
11 OA publications in the last year
Leading citing country
United States
872 citing publications
Leading citing field
Oncology
501 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v5n1,Feb. 1982-
v5n1,Feb. 1982-
Active Coverage
Research Focus & Classification
Indexed Subjects
Oncology
Breast Cancer
Lung Cancer
Immunology
Liver & Colon Cancer
Digestive Disorders
Issuing & Sponsoring Bodies
Contributor
American Radium Society
Broad Categories
Neoplasms
Breast Cancer
Prostate Cancer
Reproductive Health
Lung Cancer
Musculoskeletal & Nerve Cancer
Liver & Colon Cancer
Digestive Disorders
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/coc.0000000000001390
Open DOI
Sex Differences in Postoperative Outcomes for Men and Women With Colon Cancer in the US Military Health System
Objectives: Biological, behavioral, and health care access differences between men and women may contribute to differences in colon cancer diagnosis and treatment. We compared postoperative outcomes between men and women with colon cance...
02
DOI 10.1097/coc.0000000000001380
Open DOI
Modern Radiotherapy for Axial Giant Cell Tumor of Bone
Objectives: To evaluate outcomes of modern radiotherapy (RT) for giant cell tumor of bone (GCTB) in anatomically constrained axial sites and to assess the prognostic impact of disease burden at RT initiation. Methods: We retrospectively ...
03
DOI 10.1097/coc.0000000000001388
Open DOI
Patient-Facility Distance and Adjuvant Radiotherapy for WHO Grade 2-3 Meningioma
Objectives: Adjuvant radiotherapy (RT) is commonly used after surgery for WHO grade 2 and 3 meningioma, but the role of patient-facility distance in RT receipt and dose/fractionation choice is not well defined. We examined whether travel...
04
DOI 10.1097/coc.0000000000001385
Open DOI
Pre-Existing Anxiety and Depression as a Risk Factor for Increased Postoperative Healthcare Utilization in Spine Tumor Patients
Objectives: This study aims to elucidate the association between pre-existing anxiety and depression and postoperative outcomes in spine tumor patients. Methods: A retrospective study was performed using the national PearlDiver Mariner d...
05
DOI 10.1097/coc.0000000000001389
Open DOI
Real-World Outcomes in the Evolving Second-Line Systemic Therapy Landscape in Hepatocellular Carcinoma
Objectives: Historically, few treatments existed for hepatocellular carcinoma (HCC) until sorafenib’s approval in 2007. Meaningful treatment advances included approval of atezolizumab plus bevacizumab in 2020 and tremelimumab plus durval...
06
DOI 10.1097/coc.0000000000001383
Open DOI
Factors Contributing to Non-Initiation of Planned Systemic Therapy Among Inpatients Evaluated for a Phase II Randomized Controlled Oncology Trial
Objectives: The Spine Patient Optimal Radiosurgery Treatment for Symptomatic MEtastatic Neoplasms (SPORTSMEN) multicenter phase II randomized controlled trial evaluates radiation therapy (RT) for symptomatic spinal metastases, with 3-mon...
07
DOI 10.1097/coc.0000000000001381
Open DOI
Pancreatic Reirradiation: A Multi-Institutional Retrospective Analysis of Feasibility, Tolerability, and Clinical Outcomes
Objectives: With improvements in systemic therapy for pancreatic cancer (PC), the role of radiation therapy (RT) to optimize local control has increased. While the tolerability and outcomes for RT for PC are well described, limited data ...
08
DOI 10.1097/coc.0000000000001379
Open DOI
Dose to the Fetus in Pregnant Women Undergoing Stereotactic Radiosurgery for Brain Tumors
Objectives: Stereotactic radiosurgery (SRS) treats intracranial tumors during pregnancy when intervention cannot be delayed until delivery. However, fetal radiation exposure raises toxicity and carcinogenic concerns, especially above 50 ...
09
DOI 10.1097/coc.0000000000001382
Open DOI
Efficacy of Veliparib Plus Temozolomide Combination Therapy in Cancer
Temozolomide (TMZ) is widely used in aggressive cancers, but its efficacy may be limited by tumor DNA repair mechanisms. Inhibition of PARP with veliparib (ABT-888) has been proposed to enhance TMZ-induced cytotoxicity. We conducted this...
10
DOI 10.1097/coc.0000000000001374
Open DOI
Primary Synovial Sarcoma of the Extremities Benefits From Perioperative Radiation and Chemotherapy
Objectives: Synovial sarcoma (SS) mostly arises in the extremities, yet data focused exclusively on primary extremity tumors remain limited. Therefore, we evaluated survival outcomes in patients with localized extremity SS treated at a l...
Bibliographical & Catalog Notes
Title from cover.
Place of publication varies.
Also issued online.
Official publication of the American Radium Society, 1982-1987.
Vol. 13, no. 1 (FEB 1990)19900914 Notice not published Printed on acid-free paper